This week's news items are listed below:

 

1.     Whistleblowing

2.     New Summary Care Record (SCR) Registration Process

3.     Important information from East and North Herts CCG

4.     Important information from Herts Valleys CCG

5.     NHS logo use by pharmacies

6.     Important information on changes to Lucozade that affects hypoglycaemia treatment amounts

 

Missed a previous e-news? You can access these on the LPC website: 
http://www.hertslpc.org.uk/about-us/lpc-newsletter/
View this email in your browser

1.    Whistleblowing

NHS England expects all pharmacies to review and update existing whistleblowing policies and procedures by September 2017. Further information is available from PSNC here. If you are part of a group of pharmacies please check with your head office.

 

2.    New Summary Care Record (SCR) Registration Process

From 1 April 2017, a new process for pharmacies and pharmacy staff to register for access to Summary Care Records (SCR) was introduced. Details of the new process are outlined on the NHS Digital SCR web pages. The process to apply for SCR access will now be through the website and there will be no requirement to attend face to face training.

Over 93% of community pharmacies now have access to SCR and over 24,000 pharmacy professionals have completed the SCR eLearning.

There is eLearning on the website for community pharmacy SCR Governance Persons (SGPs) (formerly known as Privacy Officers). 

If you have any enquiries about accessing SCR, please email NHS Digital at
scrpharmacy@nhs.net.

 

3.    Important information from East and North Herts CCG

Unavailable Prescription Items
GP prescribing leads in East and North Herts CCG have requested that where prescription items are unavailable (short term or long term) that pharmacists make every effort to suggest an available alternative to avoid additional patient journeys and inconvenience.
If community pharmacies encounter problems with this method please let the LPC know so we can feed this back to the GP prescribing leads.
 
Changes to Medications
The CCG has recently emailed all pharmacies in East and North Herts CCG to inform them of upcoming changes to medication of patients in East and North Hertfordshire CCG area practices in order that you can adjust your stocks accordingly and support patients with their medicines. 
As part of the NHS efficiency savings (QIPP 2016-7), the CCG has required the pharmacy and medicines optimisation team to identify a number of potential prescribing savings that can be implemented.
These are in the form of branded generic switches as detailed below:

  • Fentanyl patches (including Durogesic, Osmanil, Yemex, Victanyl) to Fencino patches
  • Oxycodone immediate release capsules to Shortec capsules
  • Oxycodone modified release tablets to Longtec tablets

When the switches are made a script note will be included for patient information. Please support patients to positively reassure them that these changes simply reflect a change of brand / formulation and that the active ingredient remains the same and will not affect their treatment.
If community pharmacies encounter problems with these changes please feedback to your local community pharmacy representative or to the LPC.
 

4.    Important information from Herts Valleys CCG

All pharmacies should have received information from the Medicines and Optimisation Team on 31 March 2017 regarding the following issues:

01)  Summary of Alert Card Requirements
02)  QIPP Final Letter
03)  New Palliative Care Referral System
04)  Denosumab

Full information is available on the LPC website.

If community pharmacies encounter problems with any of these issues please feedback to your local community pharmacy representative or to the LPC.

5.    NHS logo use by pharmacies

In January 2017 NHS England updated the guidelines on the use of the NHS Identity, including revised guidance for all primary care contractors who are commissioned under a primary care contract. Where pharmacy contractors choose to use the NHS identity, they must ensure that the revised guidance is adhered to when producing, updating or replacing designs; the same guidance also applies to general practices, optometrists and dental practices. Full information is available on the PSNC website.

 

6.    Important information on changes to Lucozade that affects hypoglycaemia treatment amounts

The carbohydrate content of Lucozade is changing from 1 April 2017. Hypoglycaemia treatment amounts will need to be double, see the LPC website for further information.

Please remember that the opening hours for Easter are available on the LPC website along with a poster to encourage patients to order their medications in a timely way.  

Hope that you have a good weekend from all the LPC office.   

Copyright © 2017 Hertfordshire Local Pharmaceutical Committee, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

Email Marketing Powered by Mailchimp